EAM Investors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25,407
| Closed | -$2.31M | – | 279 |
|
|
2023
Q2 | $2.31M | Buy |
+25,407
| New | +$2.31M | 0.43% | 90 |
|
|
2022
Q4 | – | Sell |
-27,355
| Closed | -$1.87M | – | 254 |
|
|
2022
Q3 | $1.87M | Buy |
+27,355
| New | +$1.87M | 0.41% | 102 |
|
|
2021
Q3 | – | Sell |
-35,746
| Closed | -$2.26M | – | 287 |
|
|
2021
Q2 | $2.26M | Buy |
+35,746
| New | +$2.26M | 0.35% | 97 |
|
|
2021
Q1 | – | Sell |
-36,677
| Closed | -$2.1M | – | 335 |
|
|
2020
Q4 | $2.1M | Buy |
+36,677
| New | +$2.1M | 0.34% | 105 |
|